More Business Wire
View Older Stories View Newer Stories-
Study: CXO Misalignments Fueling the Surge in Security Threats
-
Incognito Software Systems Announces Largest TR-369 USP Deployment for Connected Home Management
-
IHI and The DAISY Foundation™ Honor Extraordinary Nurses in Patient Safety
-
Cyera Extends Leadership Team With Key Executive Appointments
-
Aurora to Present at Canaccord Genuity Sustainability Summit
-
HPE Introduces Next-Generation ProLiant Servers Engineered for Advanced Security, AI Automation and Greater Performance
-
Surgere Unveils Agentic AI Assistant, Enabling Instant Insight Into Supply Chain Data, at Manifest 2025
-
Forrester Announces Full Conference Agenda For CX Summit North America 2025
-
Peachtree Group Names Michael Brunner as Executive Vice President, Credit Investments
-
Yelp Unveils its 12th Annual Top 100 Places to Eat in the United States
-
Datavault AI Signs Interoperability License Agreement with Dolby
-
ServiceNow Launches Government Transformation Suite, Uniting High-Impact Solutions Tailored to Administration Priorities
-
Arch Insurance Publishes 2025 State Disability & Paid Family Leave Reference Guide
-
Catchpoint Helps IT Operations Teams Minimize Outages With Revolutionary Visibility Across the Complete Internet Stack Into the Application Stack
-
Aminad Consulting Earns 13 #1 Vault Rankings, Including Best Boutique Consulting Firm
-
Eaton invests in new South Carolina transformer manufacturing site to power data centers, grid modernization, electrification and industrialization
-
AltPep Corporation Appoints Alan Colowick, M.D., M.P.H. to Board of Directors
-
UWM Holdings Corporation Announces Q4 2024 and Full Year 2024 Earnings Conference Call
-
Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease
-
Schwab Makes Expanded 24-Hour Trading Available to All Clients
-
Introducing Nova-3: Extending Deepgram's Leadership in Voice AI for Enterprise Use Cases
-
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results
-
Ambac to Release Fourth Quarter 2024 Results on February 26, 2025
-
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma
-
Holley Performance Brands Launches Modern Truck & Off-Road Performance Packages
-
Germitec Secures $30 Million Financing to Accelerate U.S. Market Expansion and Drive Innovation in UV-C High-Level Disinfection
-
VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR
-
Corpay Cross-Border Launches Multi-Currency Accounts
-
Cinemark to Participate in Upcoming Institutional Investor Conferences
-
XPEL, Inc. to Host Conference Call to Discuss Fourth Quarter and Year End 2024 Results
-
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
-
The New York Stock Exchange to Launch NYSE Texas
-
Sisvel Welcomes EU SEP Regulation Rethink
-
First Real-World Outcomes Data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be Presented at 2025 ASCO Genitourinary Cancers Symposium
-
Wesleyan Impact Partners Announces 2025 Locke Innovative Leader Award Honorees
-
Thermo Fisher Scientific’s New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics
-
Merck Employees Federal Credit Union Partners with Carefull to Combat Rising Elder Fraud and Scam Threats
-
DeepTempo Completes BNY Ascent Program to Advance AI-Driven Cybersecurity Innovation
-
Alliant Insurance Services Adds Connor Foley to Southeast Benefits Team
-
Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial
-
New FICO Survey: 88% of Customers Consider Customer Experience of Equal Importance to Product Offerings When Choosing Their Bank
-
Coincheck Reports Fiscal 2025 Third Quarter Financial Results
-
One Inc Celebrates Year of Growth, Innovation, and Client Collaboration
-
The Typical Homebuyer Pays Roughly 2% Less than the List Price–The Biggest Discount in 2 Years
-
Data from a Long-Term Follow-up Study to the OLYMPUS Trial that Shows a Median Duration of Response of Nearly Four Years in Patients Achieving Complete Response with JELMYTO Published in The Journal o
-
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2024 Earnings Release and Conference Call
-
PennyMac Mortgage Investment Trust Declares First Quarter 2025 Dividends for Its Preferred Shares and Announces 2024 Dividend Tax Information
-
Lumos Expands 100% Fiber Optic Internet Across Ohio, Reaching Over 100K Homes and Businesses in the Columbus Metro
-
Zevia to Announce Fourth Quarter and Full Year 2024 Results on Wednesday, February 26, 2025
-
Executives Remain Committed to Integrating Financial and Sustainability Data, Citing Strong Benefits Despite Policy Uncertainty, New Workiva Study Finds
